{"id":6659,"date":"2023-10-12T23:05:48","date_gmt":"2023-10-12T23:05:48","guid":{"rendered":"https:\/\/palynziq.biomarin.com\/en-us\/?page_id=6659"},"modified":"2025-12-02T12:00:45","modified_gmt":"2025-12-02T12:00:45","slug":"see-the-results","status":"publish","type":"page","link":"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/","title":{"rendered":"See the results"},"content":{"rendered":"<div id=\"acf-block-6529a20de73f6\" class=\"wrapper hero-wrapper\">\n    <div class=\"hero hero-no-overlay\">\n                <div class=\"overlay\"><\/div>\n        <div class=\"wrapper\">\n            <div class=\"inner-wrapper\">\n                <div class=\"hero-content\">\n                                                                                    <h1>Over time, the majority of people reached an expert-recommended Phe level\n<\/h1>\n                                                                                                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n    <\/div>\n\n<div id=\"results-you-can-see\" class=\"block wrapped-content\">\n    <div class=\"wrapper\">\n        <div class=\"inner-wrapper\">\n                \n<div id=\"acf-block-67dad1ed8d402\" class=\"block-wysiwyg\">\n            <p>Before starting PALYNZIQ, people participating in the study had an average Phe level of <strong>20 mg\/dL<\/strong>. In a study following 118 people with PKU:<\/p>\n    <\/div>\n\n<figure id=\"acf-block-6529a20de7928\">\n    <div class=\"image image-responsive image-rounded image-align-left\">\n                    <div class=\"image-desktop\">\n\t\t\t    <img decoding=\"async\" class=\"\" src=\"https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2025\/04\/3outof4peopleChart-Desktop-1-1900x973.png\" alt=\"3 out of 4 people (89\/118) had a Phe level below or equal to 6 mg\/dL graphic\" \/>\t\t\t<\/div>\n\t\t\t<div class=\"image-mobile\">\n\t\t\t    <img decoding=\"async\" class=\"\" src=\"https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2025\/04\/3outof4Chart-Mobile-1.png?v=1.39\" alt=\"3 out of 4 people (89\/118) had a Phe level below or equal to 6 mg\/dL graphic\" \/>\t\t\t<\/div>\n            <\/div>\n            <figcaption><p>*21% of participants (25\/118) stopped taking PALYNZIQ before reaching a Phe level below or equal to 6 mg\/dL. Of those, 10 participants stopped treatment due to side effects. A total of 3% of participants (4\/118) did not reach a Phe level below or equal to 6 mg\/dL before completing the study.<\/p>\n<\/figcaption>\n    <\/figure>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div id=\"acf-block-67ee0a14bcc80\" class=\"block call-to-action call-to-action-no-overlay\">\n    <div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t\t<div class=\"box\" style=\"background-image: url(https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2023\/10\/promo_background.jpg?v=1.39);\">\n\t\t\t\t<div class=\"overlay\"><\/div>\n\t\t\t\t<div class=\"cta-content\">\n\t\t\t\t    \t\t\t\t\t<div class=\"cta-content-main\">\n                        <div class=\"content-block\">\n\t\t\t\t\t        \t\t\t\t\t        \t\t\t\t\t\t        <h2 class=\"h3\">In fact, most people taking PALYNZIQ eventually reached a Phe level below or equal to 2 mg\/dL.\n<\/h2>\n\t\t\t\t\t\t    \t\t\t\t\t\t    \t\t\t\t\t    <\/div>\n\t\t\t\t\t                        <\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"acf-block-6529aab7a1ee8\" class=\"block wrapped-content block-zero-top\">\n    <div class=\"wrapper\">\n        <div class=\"inner-wrapper\">\n                \n<figure id=\"acf-block-67dad1ed8d8da\">\n    <div class=\"image image-responsive image-rounded image-align-left\">\n                    <div class=\"image-desktop\">\n\t\t\t    <img decoding=\"async\" class=\"\" src=\"https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2025\/10\/MoreThan2outofChart-Desktop-1900x780.png\" alt=\"more than 2 out of 3 people (79\/118) reached a Phe level of below or equal to 2 mg\/dL\" \/>\t\t\t<\/div>\n\t\t\t<div class=\"image-mobile\">\n\t\t\t    <img decoding=\"async\" class=\"\" src=\"https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2025\/10\/MoreThan2outofChart-Mobile.png?v=1.39\" alt=\"more than 2 out of 3 people (79\/118) reached a Phe level of below or equal to 2 mg\/dL\" \/>\t\t\t<\/div>\n            <\/div>\n            <figcaption><p><sup>\u2020<\/sup>24% of participants (28\/118) stopped taking PALYNZIQ before they reached a Phe level below or equal to 2 mg\/dL. Additionally, 11 participants did not reach a Phe level below or equal to 2 mg\/dL before completing the study.<\/p>\n<p>Reaching a Phe level below 0.5 mg\/dL is called HypoPhe. If your Phe level decreases below 0.5 mg\/dL while taking PALYNZIQ, your doctor may reduce your dose and\/or modify your diet to increase it.<\/p>\n<\/figcaption>\n    <\/figure>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div id=\"acf-block-66deb38a257a0\" class=\"block split-content equal-bias block-tight-top block-tight-bottom\" data-muted-autoplay=\"false\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t                                                                <div class=\"content-block first-block\">\n                                                                                                                                                                                                                                                <div class=\"video-poster\">\n\t\t\t                            <a class=\"modal-video permitted\" href=\"http:\/\/player.vimeo.com\/video\/1020756372\" style=\"background-image: url(https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2025\/02\/TakesTimetoEfficacy_Thumbnail-v1.jpg?v=1.39);\">Play<\/a>\n\t\t                            <\/div>\n                                    \n                                                                                                                    \n                                                                                                                \n\t\t                                                                            <\/div>\n                    \n                                            <div class=\"content-block second-block\">\n                                                                                                <h2><em>Real Talk:<\/em> A lower Phe level takes time<\/h2>\n<p>Hear firsthand from real adults with PKU about the process of lowering Phe levels.<\/p>\n                                                                                    <\/div>\n                                                \t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"acf-block-6529aab7a2296\" class=\"block call-to-action call-to-action-no-overlay\">\n    <div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t\t<div class=\"box\" style=\"background-image: url(https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2023\/10\/promo_background.jpg?v=1.39);\">\n\t\t\t\t<div class=\"overlay\"><\/div>\n\t\t\t\t<div class=\"cta-content\">\n\t\t\t\t    \t\t\t\t\t<div class=\"cta-content-main\">\n                        <div class=\"content-block\">\n\t\t\t\t\t        \t\t\t\t\t        \t\t\t\t\t\t        <h2 class=\"h3\">Your clinic team will monitor your Phe levels and suggest any changes to your dose or diet to help you reach your goals.\n<\/h2>\n\t\t\t\t\t\t    \t\t\t\t\t\t    \t\t\t\t\t    <\/div>\n\t\t\t\t\t                        <\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n<div id=\"acf-block-6807bb4881941\" class=\"block wrapped-content\">\n    <div class=\"wrapper\">\n        <div class=\"inner-wrapper\">\n                \n<div id=\"acf-block-6807ba95e35a2\" class=\"block boxed-content top-border\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t\t<div class=\"box\">\n\t\t\t\t\t\t\t\t\n<div id=\"acf-block-6807ba95e37a0\" class=\"block-wysiwyg\">\n            <h2>Diet or no diet, you can start PALYNZIQ<\/h2>\n<p><strong>Most people did NOT consume a Phe-restricted diet while taking PALYNZIQ.<\/strong><\/p>\n<p>A Phe-restricted diet is when people get more than 75% of their protein from medical food\/formula.<\/p>\n<p>A separate analysis of the 250 people taking PALYNZIQ during a clinical study found that*:<\/p>\n    <\/div>\n\n<div id=\"acf-block-67dbfced797d3\" class=\"image-text-block content-align-center bottom-border\">\n            <div class=\"image-block medium\">\n            <figure>\n                <div class=\"image image-rounded\">\n                    <img decoding=\"async\" class=\"\" src=\"https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2025\/03\/84.png?v=1.39\" alt=\"84%\" \/>                <\/div>\n            <\/figure>\n        <\/div>\n        <div class=\"content-block\">\n                            <p><strong>were not on a Phe-restricted diet before starting PALYNZIQ.<\/strong><\/p>\n                    <\/div>\n<\/div>\n\n<div id=\"acf-block-67dbfced79845\" class=\"image-text-block content-align-center block-zero-bottom\">\n            <div class=\"image-block medium\">\n            <figure>\n                <div class=\"image image-rounded\">\n                    <img decoding=\"async\" class=\"\" src=\"https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2025\/03\/94.png?v=1.39\" alt=\"94%\" \/>                <\/div>\n            <\/figure>\n        <\/div>\n        <div class=\"content-block\">\n                            <p><strong>were not on a Phe-restricted diet at their last assessment at the end of the study.<\/strong><\/p>\n                    <\/div>\n<\/div>\n\n<div id=\"acf-block-67dbfd894ab32\" class=\"block-wysiwyg\">\n            <p><small>*40% of patients (101\/250) were taking no medical protein before starting. About 91% (92\/101) of them still did not take any medical protein at their last assessment.<br \/>\n<\/small><small>43% (108\/250) were taking some form of medical protein before starting. About 48% (52\/108) of them still did so at their last assessment.<br \/>\n<\/small><small>16% (41\/250) got more than 75% of their protein from medical food\/formula before starting. About 29% (12\/41) still did so at their last assessment.<\/small><small><\/small><\/p>\n    <\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div id=\"acf-block-6529b0e883267\" class=\"block cards cards-2-col\">\n\t<div class=\"wrapper\">\n\t\t<div class=\"inner-wrapper\">\n\t\t\t<div class=\"cards-title\">\n\t\t\t    \t\t\t\t\t\t\t<\/div>\n\t\t\t<div class=\"cards-wrapper\">\n\t\t\t    \n<div id=\"acf-block-6529b0e8837ca\" class=\"card card-fixed-button card-centered card-inner-image card-inner-image-medium\" data-muted-autoplay=\"false\">\n        <div class=\"card-content\">\n                    <img decoding=\"async\" class=\"\" src=\"https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2023\/10\/stay_connected_icon.png?v=1.39\" alt=\"\" \/>                            <h4>Stay in the loop with news and updates about PALYNZIQ\n<\/h4>\n        \n                                                                                                                                                                                                                                                                                    \n                                                                                        <\/div>\n                                <div class=\"card-actions\">\n                            \n                            <p><a class=\"button button-arrow\" href=\"https:\/\/palynziq.biomarin.com\/en-us\/connect-with-us\/\" target=\"_self\">Connect with us<\/a><\/p>\n                                                                                    <\/div>\n<\/div>\n\n<div id=\"acf-block-6529b0e88386a\" class=\"card card-fixed-button card-centered card-inner-image card-inner-image-medium\" data-muted-autoplay=\"false\">\n        <div class=\"card-content\">\n                    <img decoding=\"async\" class=\"\" src=\"https:\/\/palynziq.biomarin.com\/en-us\/wp-content\/uploads\/sites\/3\/2023\/10\/BioMarin_RareConnections_Icon.png?v=1.39\" alt=\"\" \/>                            <h4>Learn about insurance coverage and more\n<\/h4>\n        \n                                                                                                                                                                                                                                                                                    \n                                                                                        <\/div>\n                                <div class=\"card-actions\">\n                            \n                            <p><a class=\"button button-arrow\" href=\"https:\/\/palynziq.biomarin.com\/en-us\/find-pku-support\/\" target=\"_self\">Find support<\/a><\/p>\n                                                                                    <\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-6659","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>See the results - BioMarin Palynziq Patient EN-US<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"See the results - BioMarin Palynziq Patient EN-US\" \/>\n<meta property=\"og:url\" content=\"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/\" \/>\n<meta property=\"og:site_name\" content=\"BioMarin Palynziq Patient EN-US\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-02T12:00:45+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/\",\"url\":\"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/\",\"name\":\"See the results - BioMarin Palynziq Patient EN-US\",\"isPartOf\":{\"@id\":\"https:\/\/palynziq.biomarin.com\/en-us\/#website\"},\"datePublished\":\"2023-10-12T23:05:48+00:00\",\"dateModified\":\"2025-12-02T12:00:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/palynziq.biomarin.com\/en-us\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"See the results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/palynziq.biomarin.com\/en-us\/#website\",\"url\":\"https:\/\/palynziq.biomarin.com\/en-us\/\",\"name\":\"BioMarin Palynziq Patient EN-US\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/palynziq.biomarin.com\/en-us\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"See the results - BioMarin Palynziq Patient EN-US","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/","og_locale":"en_US","og_type":"article","og_title":"See the results - BioMarin Palynziq Patient EN-US","og_url":"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/","og_site_name":"BioMarin Palynziq Patient EN-US","article_modified_time":"2025-12-02T12:00:45+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/","url":"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/","name":"See the results - BioMarin Palynziq Patient EN-US","isPartOf":{"@id":"https:\/\/palynziq.biomarin.com\/en-us\/#website"},"datePublished":"2023-10-12T23:05:48+00:00","dateModified":"2025-12-02T12:00:45+00:00","breadcrumb":{"@id":"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/palynziq.biomarin.com\/en-us\/see-the-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/palynziq.biomarin.com\/en-us\/"},{"@type":"ListItem","position":2,"name":"See the results"}]},{"@type":"WebSite","@id":"https:\/\/palynziq.biomarin.com\/en-us\/#website","url":"https:\/\/palynziq.biomarin.com\/en-us\/","name":"BioMarin Palynziq Patient EN-US","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/palynziq.biomarin.com\/en-us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/palynziq.biomarin.com\/en-us\/wp-json\/wp\/v2\/pages\/6659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/palynziq.biomarin.com\/en-us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/palynziq.biomarin.com\/en-us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/palynziq.biomarin.com\/en-us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/palynziq.biomarin.com\/en-us\/wp-json\/wp\/v2\/comments?post=6659"}],"version-history":[{"count":351,"href":"https:\/\/palynziq.biomarin.com\/en-us\/wp-json\/wp\/v2\/pages\/6659\/revisions"}],"predecessor-version":[{"id":10619,"href":"https:\/\/palynziq.biomarin.com\/en-us\/wp-json\/wp\/v2\/pages\/6659\/revisions\/10619"}],"wp:attachment":[{"href":"https:\/\/palynziq.biomarin.com\/en-us\/wp-json\/wp\/v2\/media?parent=6659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}